Science + Tech
November 30, 2011
One of the earliest known impairments caused by Alzheimer’s disease—loss of sense of smell—can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a ӰƵ School of Medicine researcher finds. The study confirms that the…
November 30, 2011
CLEVELAND - One of the earliest known impairments caused by Alzheimer’s disease - loss of sense of smell – can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a ӰƵ School of Medicine researcher finds. The study confirms…
November 28, 2011
A hard probe inserted in the cerebral cortex of a rat model turns nearly as pliable as the surrounding gray matter in minutes, and it induces less of the tough scarring that walls off hard probes that do not change, researchers at ӰƵ have found. In the first test of…
November 22, 2011
CLEVELAND - ӰƵ School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart…
November 14, 2011
CLEVELAND - University Hospitals (UH) Case Medical Center, ӰƵ School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting…
November 10, 2011
CLEVELAND - Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio, which is co-sponsored by ӰƵ School of Medicine. More than 80 abstracts will be presented at the annual…
November 07, 2011
CLEVELAND - ӰƵ School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin – Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals…
November 02, 2011
CLEVELAND - Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients.…
October 24, 2011
Osteoporosis is blamed for backbone fractures. The real culprit could well be our own vertebrae, which evolved to absorb the pounding of upright walking, researchers at ӰƵ say. Compared to apes, humans have larger, more porous vertebrae encased in a much thinner shell…
October 22, 2011
CLEVELAND - “Say ‘ahhh.’” That is what ӰƵ student doctors and nurses will be telling patients with sore throats and other health problems Saturday, Oct. 22, during the grand opening of the Student-Run Free Clinic at The Free Medical Clinic of Greater Cleveland, 12201…